InsightsStrategy & Competition

GE is worth more in pieces than it ever was whole. Over $600 billion more.

By Uttam Dinodia2 min readView this post on LinkedIn

There is a 1987 idea that explains why, and most boards still ignore it.

In Strategies and Styles, Michael Goold and Andrew Campbell found that well over half of the world's multi-business companies are worth less than the sum of their parts.

By default, the centre is a cost, not a multiplier.

The rare ones that add value share one habit. They pick a single parenting style and match it to the portfolio they own. There are three:

  • Financial Control. HQ sets tight financial targets, businesses run autonomously. Berkshire Hathaway. GE under Welch.
  • Strategic Control. HQ coordinates and reviews. Mixed targets. Unilever. Tata.
  • Strategic Planning. HQ drives strategy around shared competences. Few related businesses. Canon.

The damage comes from mixing the styles. GE is the clearest case.

Welch ran GE as Financial Control for two decades. Hundreds of divestitures, ruthless portfolio discipline. By 2001, GE was worth $400 billion.

His successors layered Strategic Control on top. They chased cross-business gains that never arrived, expanded GE Capital, and built an oversight layer that looked sharp in slide decks and failed in the market.

The market punished the mismatch for fifteen years.

In April 2024, GE separated into three pure-play companies. By mid-2026, their combined market cap topped $600 billion, roughly 9x what GE was worth as a whole in 2022. Elliott Management is now applying the same playbook to Honeywell.

Every board faces one uncomfortable test:

Is this business worth more under you than under any other owner?

Few centres can answer that honestly. The market answers for them anyway.

GE proved the pieces can be worth more than the whole. Elliott is betting Honeywell is next.

Which conglomerate is most overdue for a breakup? Name it.

Uttam Dinodia

Uttam Dinodia

Pharmaceutical Business Consultant & Executive Director, A One Afro Limited

Over 22 years in pharmaceutical supply. Helps international manufacturers and Zambian institutions with public tenders, ZAMRA regulatory pathways and distribution.